Segment Information - Reportable Segment Information (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Net sales:
Net sales	$ 3,307	$ 3,089	$ 6,533	$ 5,554
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	700	679	1,402	1,248
Other Depreciation and Amortization	301	322	604	564
Restructuring and other charges, net	(7)	(24)	(9)	(28)
Gains on sales of fixed assets	2	0	2	0
Impairment of long-lived assets	(120)	0	(120)	0
Shareholder Activism Related Costs	0	0	(3)	(7)
Business Divestiture Costs	(30)	(5)	(60)	(5)
Severance Costs	0	(3)	(4)	(6)
Transaction related costs	(1)	0	(1)	0
Interest expense	(77)	(77)	(149)	(142)
Other (expense) income, net	(6)	11	10	18
Income before taxes	130	44	415	(10)
Corporate and Other
Segment Adjusted Operating EBITDA:
Integration-related costs	(30)	(18)	(48)	(56)
Restructuring and other charges, net	(7)	(24)	(9)	(28)
Health & Biosciences
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net	(1)	(4)	(1)	(4)
Pharma Solutions
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net	0	(1)	0	(1)
Taste
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net	(1)	(17)	(3)	(20)
Scent [Member]
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net	(5)	(2)	(5)	(3)
Operating Segments | Health & Biosciences
Net sales:
Net sales	665	639	1,326	1,065
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	184	190	376	318
Operating Segments | Pharma Solutions
Net sales:
Net sales	244	232	493	394
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	58	48	123	91
Operating Segments | Taste
Net sales:
Net sales	1,818	1,668	3,549	2,976
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	365	324	694	594
Operating Segments | Scent [Member]
Net sales:
Net sales	580	550	1,165	1,119
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	93	117	209	245
Nutrition & Biosciences, Inc
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net			(38)
Nutrition & Biosciences, Inc | Corporate and Other
Segment Adjusted Operating EBITDA:
N&B Inventory Step-Up Costs	0	(195)	0	(377)
Transaction related costs	0	(2)	0	(91)
Frutarom | Corporate and Other
Segment Adjusted Operating EBITDA:
Transaction related costs	$ 0	$ 0	$ (1)	$ 0